Saturday, June 22, 2024
wellness India Expo
Home Tags Lundbeck India

Tag: Lundbeck India

DCGI approves Brintellix in India for major depressive disorder

Lundbeck India has announced the launch of Brintellix (Vortioxetine), a novel multimodal antidepressant, which has been specifically designed to inhibit serotonin reuptake and modulate serotonergic receptor activity of the neurons in the brain of affected patients...…………...